Category Specific RSS

Categories: News

Grain storage pests no match for Bio-Gene after Flavocide trials reach six-month mark

Since the commencement of their program to fight grain storage pests, Agriculture technology company Bio-Gene Technology (ASX: BGT) continues to report strong trial results with current trials reaching the six-month mark and still effectively preventing pest growth. 

As the world population continues expanding and higher food storage levels are required, loss of grains and grain-based products caused by insects and pests will emerge as a growing problem. These losses range from 10% product loss in temperate regions to 50% in tropical areas. 

Conducting the grain storage research trials in partnership with the Department of Agriculture & Fisheries, Queensland Government (DAF), Bio-Gene’s product Flavocide is proving an effective insecticide against the offspring of adult Lesser grain borers, a major grain storage pest. 

“We are delighted that this most recent trial work, to demonstrate the long-term efficacy of Flavocide, has proven to be positive,” said Bio-Gene CEO, Richard Jagger. 

“An increase from 3 months to 6 months residual control is an excellent outcome. This will hopefully create significant potential for commercial opportunities. 

“These results clearly demonstrate the potential for incorporating Flavocide into grain protection pest management programs and further strengthens the commercial viability of our product.”

Bio-Gene will now extend the testing to a nine-month assessment, continuing to test the efficacy of Flavocide and in combination with other chemical variants and against a broader range of target pests.

Similar to the human trend of increasing resistance to broad spectrum antibiotics as a result of continued generational use, pests are becoming increasingly resistant to older ranges of insecticides. As this problem increases alongside human food consumption trajectories, the protection for stored grain will become a rising economic necessity where grain used for domestic human consumption must not contain live insects. 

Alfred Chan

Alfred Chan is a Business Reporter at The Sentiment specialising in ASX-listed small cap companies, a bloodstock enthusiast and former equities analyst.

Recent Posts

Monash University Partners with HITIQ to Advance Concussion Science Using Smart Mouthguards

A major Australian research initiative is set to push forward global understanding of brain injury,…

15 hours ago

Harris Technology targets return to profitability amid surging Refurbished Tech sales and Apple expansion

Following a successful FY25 which saw a boost in gross profit after launching its refurbished…

1 week ago

Pivotal Metals Secures $5.4M to Fast-Track Quebec Drill Program

Pivotal Metals (ASX:PVT) has locked in $5.4 million in fresh funding to accelerate exploration across…

2 weeks ago

Biotron Expands into Anaesthetics with Sedarex Acquisition and $2.5m Raise

Biotech company Biotron Limited (ASX:BIT) has announced a bold step into the anaesthetics sector, acquiring…

3 weeks ago

DroneShield Boosts Defence Capability with $13 Million Adelaide R&D Investment

DroneShield (ASX:DRO) is expanding its Australian footprint with a $13 million investment to establish a…

1 month ago

Stakk Secures T-Mobile Contract to Power Super App Expansion

Australian fintech Stakk (ASX:SKK) has signed a three-year agreement with U.S. telecommunications giant T-Mobile USA,…

1 month ago